Viewpoint: Medical MJ Resked: Implications for Insurance Coverage, Capacity and Compliance
The Department of Justice issued an order on April 23, rescheduling state-licensed medical marijuana and Food & Drug Administration-approved cannabis products to Schedule III of the Controlled Substances Act (CSA). The order is also expected to jumpstart the stalled Drug …
Original Source
Read the full article at Insurancejournal →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.